Stockscreener 앱 받기
0.3905
2.38%
-0.0095
Entero Therapeutics Inc 주식(ENTO)의 최신 뉴스
Gastroparesis Pipeline Appears Robust With 8+ Key Pharma - openPR.com
Gastroparesis Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
NuCana Stock Price, Quotes and Forecasts | NASDAQ:NCNA - Benzinga
More than 1 million power banks recalled after some consumers report fires - The Globe and Mail
FluroTech Ltd. Announces Change in Directors - TradingView
Thinkific Announces Closing of Secondary Offering of Approximately C$14.5 Million of Rhino Group's Shares - The Globe and Mail
Entero Therapeutics names Richard Paolone interim CEO - MSN
BMO Launches Human Capital Factor US Equity ETF - The Globe and Mail
Should You Buy Nio Stock Right Now? - The Globe and Mail
Celiac Disease Market Analysis 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Statistics, Revenue, Prevalence, Medication, Treatment Market and Companies by DelveInsight - The Globe and Mail
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Entero Therapeutics IncNow Offering 15.2 Million Shares Of Common Stock - marketscreener.com
Public market insider buying at Goldshore Resources (GSHR) - The Globe and Mail
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Cattle Strength Pushes Triple Digit Gains at Midday - The Globe and Mail
New ETF Will Track The Holdings Of Investor Bill Ackman - The Globe and Mail
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
Entero Therapeutics, Inc. SEC 10-Q Report - TradingView
Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement - marketscreener.com
Entero Therapeutics Finalizes Settlement with Mattress Liquidators - TipRanks
Entero (ENTO) Announces Public Offering of 16.67 Million Shares - GuruFocus
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
MMM Earnings: 3M Warns of Tariff Impacts - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Entero Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa
Entero Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com
SNDL Announces Listing on the CSE - The Globe and Mail
Titan Environmental Solutions Inc. Appoints Edward J. Borkowski and Edward F. Feighan to its Board of Directors - The Manila Times
Strategic Board Shake-Up: Ex-Pharma CFO and Former Congressman Join Titan Environmental's Expansion Push - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - ACCESS Newswire
Entero Therapeutics Delays 10-K Filing - TipRanks
Celiac Disease Pipeline: Pioneering Progress with 25+ Leading - openPR.com
VOO ETF News, 4/1/2025 - The Globe and Mail
Tesla Inc. (TSLA) Stock Analysis & Analyst Coverage Update - The Globe and Mail
Entero Therapeutics Enters Rescission Deal to Unwind Merger With ImmunogenX - MarketScreener
Entero Therapeutics slips 7%, signs rescission agreement with ImmunogenX - MSN
Strategic Shift: Entero Therapeutics Unwinds Recent Merger and Strengthens Leadership - Stock Titan
Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC - Yahoo Finance
Micron (MU) Stock Trades Down, Here Is Why - The Globe and Mail
Johnson & Johnson plans $55 billion in US investments over the next four years - The Globe and Mail
Hogs Close with Weakness on Thursday - The Globe and Mail
0.39%
0.42%
자본화:
|
볼륨(24시간):